159 related articles for article (PubMed ID: 28587321)
1. Clinical evaluation of CENP-B and Scl-70 autoantibodies in silicosis patients.
Lee S; Hayashi H; Kumagai-Takei N; Matsuzaki H; Yoshitome K; Nishimura Y; Uragami K; Kusaka M; Yamamoto S; Ikeda M; Hatayama T; Fujimoto W; Otsuki T
Exp Ther Med; 2017 Jun; 13(6):2616-2622. PubMed ID: 28587321
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy and predictive value of autoantibody profiles in patients with systemic sclerosis: a single-center study.
Zhang X; Zhang H; Zhao J; Li Y; Wang H; Li C
Clin Rheumatol; 2023 May; 42(5):1297-1306. PubMed ID: 36604358
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population.
Liu C; Hou Y; Yang Y; Xu D; Li L; Li J; Wen X; Zeng X; Zhang F; Li Y
Clin Chim Acta; 2019 Apr; 491():121-125. PubMed ID: 30685360
[TBL] [Abstract][Full Text] [Related]
4. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
Chang WS; Schollum J; White DH; Solanki KK
Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
[TBL] [Abstract][Full Text] [Related]
6. Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype.
Fritzler MJ; Hudson M; Choi MY; Mahler M; Wang M; Bentow C; Milo J; Baron M;
Autoimmun Rev; 2018 Mar; 17(3):267-275. PubMed ID: 29369808
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients.
Hayashi H; Maeda M; Murakami S; Kumagai N; Chen Y; Hatayama T; Katoh M; Miyahara N; Yamamoto S; Yoshida Y; Nishimura Y; Kusaka M; Fujimoto W; Otsuki T
Int J Immunopathol Pharmacol; 2009; 22(1):53-62. PubMed ID: 19309552
[TBL] [Abstract][Full Text] [Related]
8. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
[TBL] [Abstract][Full Text] [Related]
9. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
10. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
[TBL] [Abstract][Full Text] [Related]
11. Serological profile of patients with systemic sclerosis.
Wielosz E; Dryglewska M; Majdan M
Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
[TBL] [Abstract][Full Text] [Related]
12. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC
Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121
[TBL] [Abstract][Full Text] [Related]
13. Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis.
Volpe A; Ruzzenente O; Caramaschi P; Pieropan S; Tinazzi I; Carletto A; Bambara LM; Biasi D
Rheumatol Int; 2009 Jul; 29(9):1073-9. PubMed ID: 19194705
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival.
Watad A; McGonagle D; Bragazzi NL; Tiosano S; Comaneshter D; Shoenfeld Y; Cohen AD; Amital H
Oncoimmunology; 2019; 8(6):e1588084. PubMed ID: 31069155
[No Abstract] [Full Text] [Related]
15. Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?
Janardana R; Nair AM; Surin AK; Prakash JAJ; Gowri M; Danda D
Clin Rheumatol; 2019 Nov; 38(11):3179-3187. PubMed ID: 31309339
[TBL] [Abstract][Full Text] [Related]
16. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis.
Santiago M; Baron M; Miyachi K; Fritzler MJ; Abu-Hakima M; Leclercq S; Bell M; Hudson M; Mathieu JP; Taillefer S; Jones N; Docherty P; Khraishi M; Markland J; Pope J; Robinson D; Smith D; Sutton E
Clin Rheumatol; 2008 Jan; 27(1):77-83. PubMed ID: 17570008
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
[TBL] [Abstract][Full Text] [Related]
19. Combining EL4-B5-based B-cell stimulation and phage display technology for the successful isolation of human anti-Scl-70 autoantibody fragments.
Weber M; Weiss E; Engel AM
J Immunol Methods; 2003 Jul; 278(1-2):249-59. PubMed ID: 12957412
[TBL] [Abstract][Full Text] [Related]
20. Environmental factors producing autoimmune dysregulation--chronic activation of T cells caused by silica exposure.
Lee S; Hayashi H; Maeda M; Chen Y; Matsuzaki H; Takei-Kumagai N; Nishimura Y; Fujimoto W; Otsuki T
Immunobiology; 2012 Jul; 217(7):743-8. PubMed ID: 22226303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
